N+1 Singer shares its H1 2018 Review

In our H1 review, we discuss the UK economic and equity market environment and notable transactions completed in the first half of 2018.

Renalytix AI Plc: Successful fundraising and proposed admission to AIM

EKF Diagnostics Holdings Plc (AIM: EKF), the AIM-traded medical diagnostics business, has recently announced that Renalytix AI Plc, a spin-out from EKF, has conditionally raised gross funds of a minimum of £21 million in connection with

Read More
Tufton Oceanic Assets Limited Placing and Offer of C Shares raising US$78.4 million

Tufton Oceanic Assets Limited recently announced that it has raised gross proceeds of US$78.4 million by way of a Placing and Offer for Subscription of C Shares. This represents a follow on raise from the Company’s

Read More
N+1 Singer appoints Richard Hickinbotham as Head of Research

N+1 Singer is pleased to announce the appointment of Richard Hickinbotham as its Head of Research with effect from 1st October 2018. Richard’s appointment demonstrates the firm’s commitment to build a high quality research product that

Read More

Transaction Highlights

Renalytix AI Plc

Date: October 2018

Sector: Healthcare & Life Sciences

Type: Fundraising and proposed admission to AIM

£21.0 million

Tufton Oceanic Assets Limited

Date: October 2018

Sector: General Financials

Type: Placing and Offer of C Shares

$78.4 million

Future Plc

Date: August 2018

Sector: Media

Type: Placing

£105.7 million

Communications about our events, transactions and industries.